The ubiquitin-like protein FAT10 forms covalent conjugates and induces apoptosis

被引:142
作者
Raasi, S [1 ]
Schmidtke, G [1 ]
Groettrup, M [1 ]
机构
[1] Kantonsspital St Gallen, Res Dept, La Forsch Abt, CH-9007 St Gallen, Switzerland
关键词
D O I
10.1074/jbc.M105139200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
FAT10 is a ubiquitin-like protein that is encoded in the major histocompatibility complex class I locus and is synergistically inducible with interferon-gamma and tumor necrosis factor alpha. The molecule consists of two ubiquitin-like domains in tandem arrangement and bears a conserved diglycine motif at its carboxyl terminus commonly used in ubiquitin-like proteins for isopeptide linkage to conjugated proteins. We investigated the function of FAT10 by expressing murine FAT10 in a hemagglutinin-tagged wild type form as well as a diglycine-deficient mutant form in mouse fibroblasts in a tetracycline-repressible manner. FAT10 expression did not affect major histocompatibility complex class I cell surface expression or antigen presentation. However, we found that wild type but not mutant FAT10 caused apoptosis within 24 h of induction in a caspase-dependent manner as indicated by annexin V cell surface staining and DNA fragmentation. Wild type FAT10, but not its diglycine mutant, was covalently conjugated to thus far unidentified proteins, indicating that specific FAT10 activating and conjugating enzymes must be operative in unstimulated fibroblasts. Because FAT10 expression causes apoptosis and is inducible with tumor necrosis factor alpha, it may be functionally involved in the programmed cell death mediated by this cytokine.
引用
收藏
页码:35334 / 35343
页数:10
相关论文
共 37 条
[21]  
PFIZENMAIER K, 1987, J IMMUNOL, V138, P975
[22]  
Raasi S, 1999, EUR J IMMUNOL, V29, P4030, DOI 10.1002/(SICI)1521-4141(199912)29:12<4030::AID-IMMU4030>3.0.CO
[23]  
2-Y
[24]   Rad6-dependent ubiquitination of histone H2B in yeast [J].
Robzyk, K ;
Recht, L ;
Osley, MA .
SCIENCE, 2000, 287 (5452) :501-504
[25]  
Rotin D, 2000, J MEMBRANE BIOL, V176, P1
[26]   How an inhibitor of the HIV-I protease modulates proteasome activity [J].
Schmidtke, G ;
Holzhütter, HG ;
Bogyo, M ;
Kairies, N ;
Groll, M ;
de Giuli, R ;
Emch, S ;
Groettrup, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (50) :35734-35740
[27]   The selective proteasome inhibitors lactacystin and epoxomicin can be used to either up- or down-regulate antigen presentation at nontoxic doses [J].
Schwarz, K ;
de Giuli, R ;
Schmidtke, G ;
Kostka, S ;
van den Broek, M ;
Kim, KP ;
Crews, CM ;
Kraft, R ;
Groettrup, M .
JOURNAL OF IMMUNOLOGY, 2000, 164 (12) :6147-6157
[28]   Overexpression of the proteasome subunits LMP2, LMP7, and MECL-1, but not PA28α/β, enhances the presentation of an immunodominant lymphocytic choriomeningitis virus T cell epitope [J].
Schwarz, K ;
van den Broek, M ;
Kostka, S ;
Kraft, R ;
Soza, A ;
Schmidtke, G ;
Kloetzel, PM ;
Groettrup, M .
JOURNAL OF IMMUNOLOGY, 2000, 165 (02) :768-778
[29]   The use of LCMV-specific T cell hybridomas for the quantitative analysis of MHC class I restricted antigen presentation [J].
Schwarz, K ;
van den Broek, M ;
de Giuli, R ;
Seelentag, WW ;
Shastri, N ;
Groettrup, M .
JOURNAL OF IMMUNOLOGICAL METHODS, 2000, 237 (1-2) :199-202
[30]  
Schwarz K, 2000, EUR J IMMUNOL, V30, P3672, DOI 10.1002/1521-4141(200012)30:12<3672::AID-IMMU3672>3.0.CO